Syndax Pharmaceuticals, Inc. (SNDX) free cash flow

Free cash flow · fiscal 2025
-$323.17M

Syndax Pharmaceuticals, Inc. (SNDX) generated free cash flow of -$323.17M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$274.90M. Figures as of 18 Nov 2026, 12:36 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-$323.17M
Highest on record
$29.00Mfiscal 2021
Lowest on record
-$323.17Mfiscal 2025
Fiscal years on record
112014–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Syndax Pharmaceuticals, Inc. free cash flow, in more detail

Across the 11 fiscal years on record (2014–2025), the highest was $29.00M in fiscal 2021 and the lowest -$323.17M in fiscal 2025.

History · 11 fiscal years

Free cash flow by fiscal year

Syndax Pharmaceuticals, Inc. free cash flow, year by year

Syndax Pharmaceuticals, Inc. (SNDX) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-$323.17M—
2024-$274.90M—
2023-$160.60M—
2022-$133.68M 560.9% down
2021$29.00M—
2020-$71.26M—
2018-$68.72M—
2017-$47.46M—
2016-$35.42M—
2015-$2.48M—
2014-$14.40M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on SNDX

Syndax Pharmaceuticals, Inc., figure by figure

Syndax Pharmaceuticals, Inc. (SNDX) overview: price, valuation and scorecard

Syndax Pharmaceuticals, Inc. free cash flow: questions and answers

What is Syndax Pharmaceuticals, Inc.'s free cash flow?

Syndax Pharmaceuticals, Inc. (SNDX) generated free cash flow of -$323.17M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$274.90M.

What are the highest and lowest free cash flow figures on record for Syndax Pharmaceuticals, Inc.?

Across the 11 fiscal years on record (2014–2025), the highest was $29.00M in fiscal 2021 and the lowest -$323.17M in fiscal 2025.

How is Syndax Pharmaceuticals, Inc.'s free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Syndax Pharmaceuticals, Inc. it is on record here for 11 fiscal years, 2014 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Syndax Pharmaceuticals, Inc. (SNDX) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/SNDX/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.